Since the emergence of COVID-19 in the US, the FDA has released new guidance and information rapidly and continuously in a comprehensive response to the current pandemic. The guidance provides recommendations for conducting research, both for new and ongoing programs, during this complex research landscape. Our experts provide insights on the guidance and recommendations for best practices for conducting research during this pandemic.